Wolfe Research analyst Nigel Coe upgraded Emerson Electric (EMR) to Outperform from Peer Perform with a $103 price target, which represents a 19% premium to the current stock price. The stock has significantly underperformed on portfolio and capital re-allocation uncertainty, the analyst tells investors in a research note. The National Instruments (NATI) transaction "marks the start of the next phase," and the new Emerson should emerge as a higher growth and quality company, and at a significant valuation discount, says the firm.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on EMR:
- National Instruments downgraded to Hold from Buy at Jefferies
- Emerson price paid for NATI ‘net negative,’ says JPMorgan
- Emerson went against word by buying NATI, says Deutsche Bank
- National Instruments downgraded to Equal Weight at Morgan Stanley
- Emerson (NYSE:EMR) Acquires National Instruments for $60 a Share